EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS

Project description

Helping to end all forms of TB

In 2018 alone, about 10 million people became ill with tuberculosis (TB) globally and 1.5 million people died from it, placing this disease among the top 10 causes of death in the world. According to the WHO, about one fourth of the global population has been infected by Mycobacterium tuberculosis, although most infected individuals are asymptomatic. About 5-15 % of those infected develop tuberculosis and can transmit the disease. The standard TB treatment requires a 6-month course and involves the combination of several antimicrobial drugs, what makes the access and adherence to the treatment complicated. The TB epidemic has become even more serious with the rise of multidrug-resistant tuberculosis (MDR-TB) and the emergence of extensively drug-resistant TB (XDR-TB). Only half of the patients with MDR-TB are successfully treated, whereas those with XDR-TB type have few treatment options. The EU-funded project ERA4TB is accelerating development of highly active oral drugs with shortened treatment durations to help end all forms of TB by 2030.

Fields of science

• natural sciences › biological sciences › zoology › mammalogy › primatology
• medical and health sciences › clinical medicine › pneumology › tuberculosis
• natural sciences › computer and information sciences › artificial intelligence

Programme(s)

• H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
• H2020-EU.3.1.7. - Innovative Medicines Initiative 2 (IMI2)

Topic(s)

• IMI2-2018-15-08 - AMR Accelerator programme Pillar B: Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic

Call for proposal

H2020-JTI-IMI2-2018-15-two-stage
See other projects for this call

Funding Scheme

IMI2-RIA - Research and Innovation action

Coordinator

UNIVERSIDAD CARLOS III DE MADRID

Address

Calle Madrid 126
28903 Getafe (Madrid)
Spain

Activity type

Higher or Secondary Education Establishments

EU contribution

€ 5 084 941,25

Participants (30)

INSTITUT PASTEUR

France

EU contribution

€ 11 988 900

Address

Rue Du Docteur Roux 25-28
75724 Paris Cedex 15

Activity type

Research Organisations

UNIVERSIDAD DE ZARAGOZA

Spain

EU contribution

€ 4 247 900

Address

Calle Pedro Cerbuna 12
50009 Zaragoza

Activity type

Higher or Secondary Education Establishments

INSTITUT PASTEUR DE LILLE FONDATION

France

EU contribution

€ 2 853 750

Address

Rue Du Professeur Calmette 1
59019 Lille

Activity type

Research Organisations

SYNAPSE RESEARCH MANAGEMENT PARTNERS SL

Spain

EU contribution

€ 2 397 358,75

Address

Calle Velazquez 94 Planta 1
28006 Madrid

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

FORSCHUNGSZENTRUM BORSTEL

Germany

EU contribution

€ 2 287 500

Address

Parkallee 1-40
23845 Borstel

Activity type

Research Organisations

FONDATION INNOVATIVE MEDICINES FOR TUBERCULOSIS (IM4TB)

Switzerland

EU contribution

€ 22 407 250

Address

Epfl Innovation Park Batiment I
1015 Lausanne

Activity type

Other

CRITICAL PATH INSTITUTE, LIMITED

Ireland

EU contribution

€ 3 557 500

Address

33 Sir John Rogerson's
2 Dublin

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

CONSIGLIO NAZIONALE DELLE RICERCHE

Italy

EU contribution

€ 2 443 750

Address

Piazzale Aldo Moro 7
00185 Roma

Activity type

Research Organisations

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU contribution

€ 2 012 500

Address

Rue Leblanc 25
75015 Paris 15

Activity type

Research Organisations

SERVICIO MADRILENO DE SALUD

Spain

EU contribution

€ 11 377 180,50

Address

Plaza Carlos Trias Bertran 7
28020 Madrid

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

UPPSALA UNIVERSITET

Sweden

EU contribution

€ 1 797 500

Address

Von Kraemers Alle 4
751 05 Uppsala

Activity type

Higher or Secondary Education Establishments

Department of Health

United Kingdom

EU contribution

€ 1 572 500

Address

Quarry House, Quarry Hill
LS2 7UE Leeds

Activity type

Research Organisations

ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE

Switzerland

EU contribution

€ 962 500

Address

Batiment Ce 3316 Station 1
1015 Lausanne

Activity type

Higher or Secondary Education Establishments

KLINIKUM DER UNIVERSITAET ZU KOELN

Germany

EU contribution

€ 1 407 500

Address

Kerpener Strasse 62
50937 Koeln

Activity type

Higher or Secondary Education Establishments

UNIVERSITA DEGLI STUDI DI PADOVA

Italy

EU contribution

€ 615 000

Address

Via 8 Febbraio 2
35122 Padova

Activity type

Higher or Secondary Education Establishments

UNIVERSITA DEGLI STUDI DI PAVIA

Italy

EU contribution

€ 592 000

Address

Strada Nuova 65
27100 Pavia

Activity type

Higher or Secondary Education Establishments

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE

United Kingdom

EU contribution

€ 293 500

Address

Level 1A City Tower Piccadilly Plaza
M1 4BT Manchester

Activity type

Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)

IMABIOTECH SAS

France

EU contribution

€ 837 500

Address

152 Rue Du Docteur Yersin
59120 Loos

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

SCIENSANO

Belgium

EU contribution

€ 1 637 500

Address

Juliette Wytsmanstraat 14
1050 Elsene

Activity type

Research Organisations

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

Latvia

EU contribution

€ 277 500

Address

Aizkraukles 21
LV-1006 Riga

Activity type

Research Organisations

BIOASTER FONDATION DE COOPERATION SCIENTIFIQUE

France

EU contribution

€ 1 856 250

Address

40 Avenue Tony Garnier
69007 Lyon

Activity type

Research Organisations

QPS NETHERLANDS BV

Netherlands

EU contribution

€ 6 175 319,50

Address

Hanzeplein 1, Ingang 53
9713 GZ Groningen

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

LUNDS UNIVERSITET

Participation ended

Sweden

EU contribution

€ 0

Address

Paradisgatan 5C
22100 Lund

Activity type

Higher or Secondary Education Establishments

GRITSYSTEMS AS

Denmark

EU contribution

€ 1 132 500

Address

Trekronergade 126F, 3 Tv
2500 Valby

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL

Spain

EU contribution

€ 0

Address

C/ Severo Ochoa Numero 2 Parque Tecnologico De Mad
28760 Tres Cantos Madrid

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EVOTEC INTERNATIONAL GMBH

Germany

EU contribution

€ 0

Address

Essener Bogen 7
22419 Hamburg

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

JANSSEN PHARMACEUTICA NV

Belgium

EU contribution

€ 0

Address

Turnhoutseweg 30
2340 Beerse

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

BILL & MELINDA GATES FOUNDATION

United States

EU contribution

€ 0

Address

500 5Th Ave N
98102 Seattle, Washington

Activity type

Research Organisations

GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION

United States

EU contribution

€ 0

Address

Wall Street 40 24Th Floor
10005 New York

Activity type

Research Organisations

UNIVERSITY OF DUNDEE

United Kingdom

EU contribution

€ 0

Address

Nethergate
DD1 4HN Dundee

Activity type

Higher or Secondary Education Establishments